Role of cerebral cortex in the neuropathology of Huntington's disease

Frontiers in Neural Circuits

Volumn , Issue JAN, 2013, Pages

  Estrada Sánchez, Ana María ^a   Rebec, George V ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Basal ganglia; Glutamate transmission; Huntingtin; Neuronal processing

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ARTICLE; AUTOPSY; BRAIN CORTEX; BRAIN DYSFUNCTION; CORTICOSTRIATAL SYSTEM; GLUCOSE METABOLISM; HUMAN; HUNTINGTON CHOREA; LOCOMOTION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE PROJECTION; NERVE TRACT; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PHENOTYPIC VARIATION; POSITRON EMISSION TOMOGRAPHY; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS; TRANSGENIC MOUSE;

EID: 84873131905     PISSN: 16625110     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncir.2013.00019     Document Type: Article

References (144)

1. André, V. M., Cepeda, C., Venegas, A., Gomez, Y., and Levine, M. S. (2006). Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease. J. Neurophysiol. 95, 2108-2119.
2. Arzberger, T., Krampfl, K., Leimgruber, S., and Weindl, A. (1997). Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease-an in situ hybridization study. J. Neuropathol. Exp. Neurol. 56, 440-454.
3. Berke, J. D., Okatan, M., Skurski, J., and Eichenbaum, H. B. (2004). Oscillatory entrainment of striatal neurons in freely moving rats. Neuron 43, 883-896.
4. Beste, C., Konrad, C., Saft, C., Ukas, T., Andrich, J., Pfleiderer, B., Hausmann, M., and Falkenstein, M. (2009). Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentials. Exp. Neurol. 216, 148-57.
5. Beurrier, C., Bonvento, G., Kerkerian-Le Goff, L., and Gubellini, P. (2009). Role of glutamate transporters in corticostriatal synaptic transmission. Neuroscience 158, 1608-1615.
6. Bonvento, G., Sibson, N., and Pellerin, L. (2002). Does glutamate image your thoughts? Trends Neurosci. 25, 359-364.
7. Brodmann, K. (2010). Brodmann's localization in the cerebral cortex. New York: Springer.
8. Browne, S. E, and Beal, M. F. (2004). The energetics of Huntington's disease. Neurochem. Res. 29, 531-546.
9. Browne, S. E., Bowling, A. C., MacGarvey, U., Baik, M. J., Berger, S. C., Muqit, M. M., Bird, E. D., and Beal, M. F. (1997). Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653.
10. Bures, J., and Bracha, V. (1990). "The control of movements by the motor cortex," in The cerebral cortex of the rat, ed. B. Kolb and R. Tees (Cambridge, Massachusetts London, England, The MIT Press), 213-238.
11. Burns, S. P., Xing, D., and Shapley, R. M. (2010). Comparisons of the dynamics of local field potential and multiunit activity signals in macaque visual cortex. J. Neurosci. 30, 13739-13749.
12. Buzsáki, G., and Chrobak, J. J. (2005). Synaptic plasticity and self-organization in the hippocampus. Nat. Neurosci. 8, 1418-1420.
13. Cayzac, S., Delcasso, S., Paz, V., Jeantet, Y., and Cho, Y. H. (2011). Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease. Proc. Natl. Acad. Sci. U S A 108, 9280-9285.
14. Cepeda, C., Ariano, M. A., Calvert, C. R., Flores-Hernández, J., Chandler, S. H., Leavitt, B. R., Hayden, M. R., and Levine, M. S. (2001). NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res. 66, 525-539.
15. Cepeda, C., Wu, N., André, V. M., Cummings, D. M., and Levine, M. S. (2007). The corticostriatal pathway in Huntington's disease. Prog. Neurobiol. 81, 253-271.
16. Cepeda-Prado, E., Popp, S., Khan, U., Stefanov, D., Rodríguez, J., Menalled, L. B., Dow-Edwards, D., Small, S. A., and Moreno, H. (2012). R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures. J. Neurosci. 32, 6456-6467.
17. Chen, C. M. (2011). Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease. Chang. Gung. Med. J. 34, 135-152.
18. Choo, Y. S., Johnson, G. V., MacDonald, M., Detloff, P. J., and Lesort, M. (2004). Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome C release. Hum. Mol. Genet. 13, 1407-1420.
19. Cross, A. J., Slater, P., and Reynolds, G. P. (1986). Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease. Neurosci. Lett. 67, 198-202.
20. Cudkowicz, M., and Kowall, N. W. (1990). Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann. Neurol. 27, 200-204.
21. Cummings, D. M., André, V. M., Uzgil, B. O., Gee, S. M., Fisher, Y. E., and Cepeda, C. and Levine, M. S. (2009). Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J. Neurosci. 29, 10371-10386.
22. Cummings, D. M., Milnerwood, A. J., Dallérac, G. M., Vatsavayai, S. C., Hirst, M. C., and Murphy, K. P. (2007). Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease. Brain Res. Bull. 72, 103-107.
23. Cummings, D. M., Milnerwood, A. J., Dallérac, G. M., Waights, V., Brown, J. Y., Vatsavayai, S. C., Hirst, M. C., and Murphy, K. P. (2006). Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. Hum. Mol. Genet. 15, 2856-2868.
24. Cybulska-Klosowicz, A., Mazarakis, N. K., Van Dellen, A., Blakemore, C., Hannan, A. J., and Kossut, M. (2004). Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice. Neurobiol. Dis. 17, 427-434.
25. Dallérac, G. M., Vatsavayai, S. C., Cummings, D. M., Milnerwood, A. J., Peddie, C. J., Evans, K. A., Walters, S. W., Rezaie, P., Hirst, M. C., and Murphy, K. P. (2011). Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation. Neurodegener. Dis. 8, 230-239.
26. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., and Bates, G. P. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
27. De la Monte, S. M., Vonsattel, J. P., and Richardson, E. P. Jr. (1988). Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J. Neuropathol. Exp. Neurol. 47, 516-525.
28. Dunlop, D. S., McHale, D. M., and Lajtha, A. (1992). Decreased brain N-acetylaspartate in Huntington's disease. Brain Res. 580, 44-48.
29. Espinosa, J. S., and Stryker, M. P. (2012). Development and plasticity of the primary visual cortex. Neuron 75, 230-249.
30. Estrada-Sánchez, A. M., and Rebec, G. V. (2012). Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. Basal Ganglia 2, 57-66.
31. Estrada-Sánchez, A. M., Mejía-Toiber, J., and Massieu, L. (2008). Excitotoxic neuronal death and the pathogenesis of Huntington's disease. Arch. Med. Res. 39, 265-276.
32. Estrada-Sánchez, A. M., Montiel, T., and Massieu, L. (2010). Glycolysis inhibition decreases the levels of glutamate transporters and enhances glutamate neurotoxicity in the R6/2 Huntington's disease mice. Neurochem. Res. 35, 1156-1163.
33. Estrada-Sánchez, A. M., Montiel, T., Segovia, J., and Massieu, L. (2009). Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. Neurobiol. Dis. 34, 78-86.
34. Faideau, M., Kim, J., Cormier, K., Gilmore, R., Welch, M., Auregan, G., Dufour, N., Guillermier, M., Brouillet, E., Hantraye, P., Déglon, N., Ferrante, R. J., and Bonvento, G. (2010). In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Hum. Mol. Genet. 19, 3053-3067.
35. Fennema-Notestine, C., Archibald, S. L., Jacobson, M. W., Corey-Bloom, J., Paulsen, J. S., Peavy, G. M., Gamst, A. C., Hamilton, J. M., Salmon, D. P., and Jernigan, T. L. (2004). In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63, 989-95.
36. Ferrante, R. J. (2009). Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim. Biophys. Acta 1792, 506-520.
37. Foerster, O. (1936). The motor cortex of man in the light of Hughlings Jackson's doctrines. Brain 59, 135-159.
38. Gambazzi, L., Gokce, O., Seredenina, T., Katsyuba, E., Runne, H., Markram, H., Giugliano, M., and Luthi-Carter, R. (2010). Diminished activity-dependent brain-derived neurotrophic factor expression underlies cortical neuron microcircuit hypoconnectivity resulting from exposure to mutant huntingtin fragments. J. Pharmacol. Exp. Ther. 335, 13-22.
39. Gray, M., Shirasaki, D. I., Cepeda, C., André, V. M., Wilburn, B., Lu, X. H., Tao, J., Yamazaki, I., Li, S. H., Sun, Y. E., Li, X. J., Levine, M. S., and Yang, X. W. (2008). Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J. Neurosci. 28, 6182-6195.
40. Groiss, S. J., Elben, S., Reck, C., Voges, J., Wojtecki, L., and Schnitzler, A. (2011). Local field potential oscillations of the globus pallidus in Huntington's disease. Mov. Disord. 26, 2577-2578.
41. Gu, X., André, V. M., Cepeda, C., Li, S. H., Li, X. J., Levine, M. S., and Yang, X. W. (2007). Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease. Mol. Neurodegener. 2, 8.
42. Gu, X., Li, C., Wei, W., Lo, V., Gong, S., Li, S. H., Iwasato, T., Itohara, S., Li, X. J., Mody, I., Heintz, N., and Yang, X. Y. (2005). Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46, 433-444.
43. Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y., Young, A. B., Shoulson, I., Bonilla, E., and Martin J. N. (1983). A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306, 234-238.
44. Halliday, G. M., McRitchie, D. A., Macdonald, V., Double, K. L., Trent, R. J., and McCusker, E. (1998). Regional specificity of brain atrophy in Huntington's disease. Exp. Neurol. 154, 663-672.
45. Harper, P. S. (1991). Huntington's Disease. Philadelphia: W. B. Saunders.
46. Harper, P. S. (2001). "The epidemiology of Huntington's disease," in Huntington's disease, G. Bates, P. S. Harper, Jones, L., (New York. Oxford University Press), 159-197.
47. Hassel, B., Tessler, S., Faull, R. L., and Emson, P. C. (2008). Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem. Res. 33, 232-237.
48. Hasselbalch, S. G., Oberg, G., Sørensen, S. A., Andersen, A. R., Waldemar, G., Schmidt, J. F., Fenger, K., and Paulson, O. B. (1992). Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J. Neurol. Neurosurg. Psychiatry. 55, 1018-1023.
49. Hedreen, J. C., Peyser, C. E., Folstein, S. E., and Ross, C. A. (1991). Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 133, 257-261.
50. Heinsen, H., Strik, M., Bauer, M., Luther, K., Ulmar, G., Gangnus, D., Jungkunz, G., Eisenmenger, W., and Götz, M. (1994). Cortical and striatal neurone number in Huntington's disease. Acta Neuropathol. 88, 320-333.
51. Hodgson, J. G., Apopyan, N., Gutekunts, C. A., Leavitt, B. R., LePiane, F., and Singaraja, R. (1999). A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23, 181-92.
52. Höhn, S., Dallérac, G., Faure, A., Urbach, Y. K., Nguyen, H. P., Riess, O., von Hörsten, S., Le Blanc, P., Desvignes, N., El Massioui, N., Brown, B. L., and Doyère, V. (2011). Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease. J. Neurosci. 31, 8986-3997.
53. Hong, S. L., Barton, S. J., and Rebec, G. V. (2012a). Altered neural and behavioral dynamics in Huntington's disease: an entropy conservation approach. PLoS One. 7:e30879.
54. Hong, S. L., Barton, S. J., and Rebec, G.V. (2012b). Neural correlates of unpredictability in behavioral patterns of wild-type and R6/2 mice. Commun. Integr. Biol. 5, 259-261.
55. Hong, S. L., Cossyleon, D., Hussain, W. A., Walker, L. J., Barton, S. J., and Rebec, G. V. (2012c). Dysfunctional Behavioral Modulation of Corticostriatal Communication in the R6/2 Mouse Model of Huntington's Disease. PLoS One. 7, e47026.
56. Huntington's Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
57. Huntington, G. (1872). On Chorea. Med. Sur. Rep. 26, 317-321. Re-edited: Huntington, G. (2003). On chorea J. Neuropsychiatry Clin. Neurosci. 15, 109-112.
58. Ichinohe, N. (2012). Small-scale module of the rat granular retrosplenial cortex: an example of the minicolumn-like structure of the cerebral cortex. Front. Neuroanat. 5, 69.
59. Izhikevich, E. M., Desai, N. S., Walcott, E. C., and Hoppensteadt, F. C. (2003). Bursts as a unit of neural information: selective communication via resonance. Trends Neurosci. 26, 161-167.
60. Jenkins, B. G., Rosas, H. D., Chen, Y. C., Makabe, T., Myers, R., MacDonald, M., Rosen, B. R., Beal, M. F., and Koroshetz, W. J. (1998). 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers. Neurology 50, 1357-1365.
61. Jernigan, T. L., Salmon, D. P., Butters, N., and Hesselink, J. R. (1991). Cerebral structure on MRI, Part II: Specific changes in Alzheimer's and Huntington's diseases. Biol. Psychiatry. 29, 68-81.
62. Jinnai, K., and Matsuda, Y. (1979). Neurons of the motor cortex projecting commonly on the caudate nucleus and the lower brain stem in the cat. Neurosci. Lett. 13, 121-126.
63. Jones, E. G., and Pons, T. P. (1998). Thalamic and brainstem contributions to large-scale plasticity of primate somatosensory cortex. Science 282, 1121-1125.
64. Kaplan, A., and Stockwell, B. R. (2012). Therapeutic approaches to preventing cell death in Huntington disease. Prog. Neurobiol. 99, 262-280.
65. Kemp, J. M., and Powell, T. P. (1970). The cortico-striate projection in the monkey. Brain 93, 525-546.
66. Kim, J., Bordiuk, O. L., and Ferrante, R. J. (2011). Experimental models of HD and reflection on therapeutic strategies. Int. Rev. Neurobiol. 98, 419-481.
67. Klapstein, G. J., Fisher, R. S., Zanjani, H., Cepeda, C., Jokel, E. S., Chesselet, M. F., and Levine, M. S. (2001). Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J. Neurophysiol. 86, 2667-2677.
68. Kuhl, D. E., Phelps, M. E., Markham, C. H., Metter, E. J., Riege, W. H., and Winter, J. (1982). Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann. Neurol. 12, 425-434.
69. Kuwert, T., Lange, H. W., Langen, K. J., Herzog, H., Aulich, A., and Feinendegen, L. E. (1989). Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease. Psychiatry Res. 29, 361-362.
70. Kuwert, T., Lange, H. W., Langen, K. J., Herzog, H., Aulich, A., and Feinendegen, L. E. (1990). Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 113, 1405-1423.
71. Laforet, G. A., Sapp, E., Chase, K., McIntyre, C., Boyce, F. M., Campbell, M., Cadigan B. A., Warzecki, L., Tagle, D. A., Reddy, P. H., Cepeda, C., Calvert, C. R., Jokel, E. S., Klapstein, G. J., Ariano, M. A., Levine, M. S., DiFiglia, M., and Aronin, N. (2001). Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J. Neurosci. 21, 9112-9123.
72. Langbehn, D. R., Hayden, M. R., Paulsen, J. S., and PREDICT-HD Investigators of the Huntington Study Group. (2010). CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 153, 397-408.
73. Lei, W., Jiao, Y., Del Mar, N., and Reiner, A. (2004). Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J. Neurosci. 24, 8289-8299.
74. Lévesque, M., Charara, A., Gagnon, S., Parent, A., and Deschenes, M. (1996). Corticostriatal projections from layer V cells in rat are collaterals of long-range corticofugal axons. Brain Res. 709, 311-315.
75. Levine, M. S., Klapstein, G. J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M. E., Jokel, E. S., Carpenter, E. M., Zanjani, H., Hurst, R. S., Efstratiadis, A., Zeitlin, S., and Chesselet, M. F. (1999). Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J. Neurosci. Res. 58, 515-532.
76. Lisman, J. E. (1997). Bursts as a unit of neural information: making unreliable synapses reliable. Trends Neurosci. 20, 38-43.
77. Macdonald, V., and Halliday, G. (2002). Pyramidal cell loss in motor cortices in Huntington's disease. Neurobiol. Dis. 10, 378-386.
78. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., and Bates, G. P. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-406.
79. Mann, D. M., Oliver, R., and Snowden, J. S. (1993). The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol. 85, 553-559.
80. Marder, K., Zhao, H., Eberly, S., Tanner, C. M., Oakes, D., Shoulson, I., and Huntington Study Group. (2009). Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants. Neurology 73, 385-392.
81. Mazarakis, N. K., Cybulska-Klosowicz, A., Grote, H., Pang, T., Van Dellen, A., Kossut, M., Blakemore, C., and Hannan, A. J. (2005). Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice. J. Neurosci. 25, 3059-3066.
82. McBride, J. L., Ramaswamy, S., Gasmi, M., Bartus, R. T., Herzog, C. D., Brandon, E. P., Zhou, L., Pitzer, M. R., Berry-Kravis, E. M., and Kordower, J. H. (2006). Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 103, 9345-9350.
83. McGeorge, A. J., and Faull, R. L. (1989). The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29, 503-537.
84. Menalled, L. B. (2005). Knock-in mouse models of Huntington's disease. NeuroRx 2, 465-470.
85. Merchant, H., de Lafuente, V., Peña-Ortega, F., and Larriva-Sahd, J. (2012). Functional impact of interneuronal inhibition in the cerebral cortex of behaving animals. Prog. Neurobiol. 99, 163-178.
86. Milakovic, T., and Johnson, G. V. (2005). Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. J. Biol. Chem. 280, 30773-30782.
87. Milnerwood, A. J., and Raymond, L. A. (2007). Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load. J. Physiol. 585, 817-831.
88. Miller, B. R., and Bezprozvanny, I. (2010). Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium. Future Neurol. 5, 735-756.
89. Miller, B. R., Dorner, J. L., Shou, M., Sari, Y., Barton, S. J., Sengelaub, D. R., Kennedy, R. T., and Rebec, G. V. (2008a). Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience 153, 329-337.
90. Miller, B. R., Walker, A. G., Barton, S. J., and Rebec, G. V. (2011). Dysregulated neuronal activity patterns implicate corticostriatal circuit dysfunction in multiple rodent models of Huntington's Disease. Front. Syst. Neurosci. 5, 1-10.
91. Miller, B. R., Walker, A. G., Fowler, S. C., von Hörsten, S., Riess, O., Johnson, M. A., and Rebec, G. V. (2010). Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease. Neurobiol. Dis. 37, 106-113.
92. Miller, B. R., Walker, A. G., Shah, A. S., Barton, S. J., and Rebec, V. G. (2008b). Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. J. Neurophysiol. 100, 2205-2216.
93. Miller, J., Arrasate, M., Brooks, E., Libeu, C. P., Legleiter, J., Hatters, D., Curtis, J., Cheung, K., Krishnan, P., Mitra, S., Widjaja, K., Shaby, B. A., Lotz, G. P., Newhouse, Y., Mitchell, E. J., Osmand, A., Gray, M., Thulasiramin, V., Saudou, F., Segal, M., Yang, X. W., Masliah, E., Thompson, L. M., Muchowski, P. J., Weisgraber, K. H., and Finkbeiner, S. (2011). Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat. Chem. Biol. 7, 925-934.
94. Miller, K. D. (2003). Understanding layer 4 of the cortical circuit: a model based on cat V1. Cereb. Cortex. 13, 73-82.
95. Nicniocaill, B., Haraldsson, B., Hansson, O., O'Connor, W. T., and Brundin, P. (2001). Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. Eur. J. Neurosci. 13, 206-210.
96. Nieuwenhuys, R. (2012). The insular cortex: a review. Prog. Brain. Res. 195, 123-163.
97. Parent, M., and Parent, A. (2006). Single-axon tracing study of corticostriatal projections arising from primary motor cortex in primates. J. Comp. Neurol. 496, 202-213.
98. Penfield, W., and Boldrey, E. (1937). Somatic motor and sensory representation in the cerebral cortex of man as studied by electrical stimulation. Brain 60, 389-443.
99. Pouladi, M. A., Stanek, L. M., Xie, Y., Franciosi, S., Southwell, A. L., Deng, Y., Butland, S., Zhang, W., Cheng, S. H., Shihabuddin, L. S., and Hayden M. R. (2012). Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum. Mol. Genet. 21, 2219-2232.
100. Pouladi, M. A., Xie, Y., Skotte, N. H., Ehrnhoefer, D. E., Graham, R. K., Kim, J. E., Bissada, N., Yang, X. W., Paganetti, P., Friedlander, R. M., Leavitt, B. R., and Hayden, M. R. (2010). Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum. Mol. Genet. 19, 1528-1538.
101. Powers, W. J., Videen, T. O., Markham, J., McGee-Minnich, L., Antenor-Dorsey, J. V., Hershey, T., and Perlmutter, J. S. (2007). Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proc. Natl. Acad. Sci. U S A 104, 2945-2949.
102. Quarrell, O., O'Donovan, K. L., Bandmann, O., and Strong, M. (2012). The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis. PLoS Curr. 4, e4f8606b742ef3.
103. Rasmussen, A., Macias, R., Yescas, P., Ochoa, A., Davila, G., and Alonso, E. (2000). Huntington disease in children: Genotype-phenotype correlation. Neuropediatrics 31, 190-194.
104. Ray, R. D., and Zald, D. H. (2012). Anatomical insights into the interaction of emotion and cognition in the prefrontal cortex. Neurosci. Biobehav. Rev. 36, 479-501.
105. Rebec, G. V., Conroy, S. K., and Barton, S. J. (2006). Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment. Neuroscience 137, 327-336.
106. Reedeker, W., van der Mast, R. C., Giltay, E. J., Kooistra, T. A., Roos, R. A., and van Duijn, E. (2012). Psychiatric disorders in Huntington's disease: a 2-year follow-up study. Psychosomatics 53, 220-229.
107. Reiner, A., Hart, N. M., Lei, W., and Deng, Y. (2010). Corticostriatal projection neurons-dichotomous types and dichotomous functions. Front. Neuroanat. 4, 142.
108. Reiner, A., Jiao, Y., Del Mar, N., Laverghetta, A. V., and Lei, W. L. (2003). Differential morphology of pyramidal tract-type and intratelencephalically projecting-type corticostriatal neurons and their intrastriatal terminals in rats. J. Comp. Neurol. 457, 420-440.
109. Rivara, C. B., Sherwood, C. C., Bouras, C., and Hof, P. R. (2003). Stereologic characterization and spatial distribution patterns of Betz cells in the human primary motor cortex. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 270, 137-51.
110. Rosas, H. D., Lee, S. Y., Bender, A. C., Zaleta, A. K., Vangel, M., Yu, P., Fischl, B., Pappu, V., Onorato, C., Cha, J. H., Salat, D. H., and Hersch, S. M. (2010). Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical disconnection. Neuroimage 49, 2995-3004.
111. Rosas, H. D., Liu, A. K., Hersch, S., Glessner, M., Ferrante, R. J., Salat, D. H., van der Kouwe, A., Jenkins, B. G., Dale, A. M., and Fischl, B. (2002). Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58, 695-701.
112. Rosas, H. D., Reuter, M., Doros, G., Lee, S. Y., Triggs, T., Malarick, K., Fischl, B., Salat, D. H., and Hersch, S. M. (2011). A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study. Mov. Disord. 26, 1691-1697.
113. Rosas, H. D., Salat, D. H., Lee, S. Y., Zaleta, A. K., Pappu, V., Fischl, B., Greve, D., Hevelone, N., and Hersch, S. M. (2008). Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 131, 1057-1068.
114. Rosas, H. D., Tuch, D. S., Hevelone, N. D., Zaleta, A. K., Vangel, M., Hersch, S. M., and Salat, D. H. (2006). Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov. Disord. 21, 1317-1325.
115. Rubio-Garrido, P., Pérez-de-Manzo, F., Porrero, C., Galazo, M. J., and Clascá, F. (2009). Thalamic input to distal apical dendrites in neocortical layer 1 is massive and highly convergent. Cereb. Cortex 19, 2380-2395.
116. Sax, D. S., Powsner, R., Kim, A., Tilak, S., Bhatia, R., Cupples, L. A., and Myers, R. H. (1996). Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography. Mov. Disord. 11, 671-677.
117. Schieber, M. H., and Baker, J. F. (2003). "Descending control of movement," in The Fundamental Neurosciences, ed. L. R. Squiere, F. E. Bloom, S. K. McConnell, J. L. Roberts, N. C. Spitzer, M. J. Zigmond (San Diego, Cal; Academic press), 802-805.
118. Schilling, G., Becher, M. W., Sharp, A. H., Jinnah, H. A., Duan, K., Kotzuk, J. A., Slunt, H. H., Ratovitski, T., Cooper, J. K., Jenkins, N. A., Copeland, N. G., Price, D. L., Ross, C. A., and Borchelt, D. R. (1999). Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 8, 397-407.
119. Sherman, S. M., and Guillery, R. W. (2011). Distinct functions for direct and transthalamic corticocortical connections. J. Neurophysiol. 106, 1068-1077.
120. Shipp, S. (2005). The importance of being agranular: a comparative account of visual and motor cortex. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360, 797-814.
121. Shipp, S. (2007). Structure and function of the cerebral cortex. Curr. Biol. 17, R443-R449.
122. Smith, R., Klein, P., Koc-Schmitz, Y., Waldvogel, H. J., Faull, R. L., Brundin, P., Plomann M., and Li, J. Y. (2007). Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease. J. Neurochem. 103, 115-123.
123. Smith, Y., Bevan, M. D., Shink, E., and Bolam, J. P. (1998). Microcircuitry of the direct and indirecty pathways of the basal ganglia. Neuroscience 86, 353-87.
124. Sotrel, A., Paskevich, P. A., Kiely, D. K., Bird, E. D., Williams, R. S., and Myers, R. H. (1991). Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 41, 1117-1123.
125. Spampanato, J., Gu, X., Yang, X. W., and Mody, I. (2008). Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease. Neuroscience 157, 606-620.
126. Stack, E. C., Kubilus, J. K., Smith, K., Cormier, K., Del Signore, S. J., Guelin, E., Ryu, H., Hersch, S. M., and Ferrante, R. J. (2005). Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J. Comp. Neurol. 490, 354-370.
127. Stern, E. A. (2011). Functional Changes in Neocortical Activity in Huntington's Disease Model Mice: An in vivo Intracellular Study. Front. Syst. Neurosci. 5, 47.
128. Szentágothai, J. (1975). The "module-concept" in cerebral cortex architecture. Brain Res. 95, 475-496.
129. Tang, T. S., Slow, E., Lupu, V., Stavrovskaya, I. G., Sugimori, M., Llinás, R., Kristal, B. S., Hayden, M. R., and Bezprozvanny, I. (2005). Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl. Acad. Sci. U S A 102, 2602-2627.
130. Thomas, E. A., Coppola, G., Tang, B., Kuhn, A., Kim, S., Geschwind, D. H., Brown, T. B., Luthi-Carter R., and Ehrlich, M. E. (2011). In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons. Hum. Mol. Genet. 20, 1049-1060.
131. Thompson, J. C., Harris, J., Sollom, A. C., Stopford, C. L., Howard, E., Snowden, J. S., and Craufurd, D. (2012). Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. J. Neuropsychiatry Clin. Neurosci. 24, 53-60.
132. Thompson, P. D., Berardelli, A., Rothwell, J. C., Day, B. L., Dick, J. P., Benecke, R., and Marsden, C. D. (1988). The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain 111, 223-244.
133. Thu, D. C., Oorschot, D. E., Tippett, L. J., Nana, A. L., Hogg, V. M., Synek, B. J., Luthi-Carter, R., Waldvogel, H. J., and Faull, R. L. (2010). Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 133, 1094-1110.
134. Unschuld, P. G., Joel, S. E., Liu, X., Shanahan, M., Margolis, R. L., Biglan, K. M., Bassett, S. S., Schretlen, D. J., Redgrave, G. W., van Zijl, P. C., Pekar, J. J., and Ross, C. A. 21 (2012). Impaired corticostriatal functional connectivity in prodromal Huntington's Disease. Neurosci. Lett. 514, 204-209.
135. Van Raamsdonk, J. M., Gibson, W. T., Pearson, J., Murphy, Z., Lu, G., Leavitt, B. R. and Hayden, M. R. (2006). Body weight is modulated by levels of full-length huntingtin. Hum. Mol. Genet. 15, 1513-1523.
136. Verwaest, K. A., Vu, T. N., Laukens, K., Clemens, L. E., Nguyen, H. P., Van Gasse, B., Martins, J. C., Van Der Linden, A., and Dommisse, R. (2011). (1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease. Biochim. Biophys. Acta. 1812, 1371-1379.
137. von Economo, C. Cellular structure of the human cerebral cortex. (1927). Translated and ed. L. C. Triarhou (2009). Karger Basel, Switzerland.
138. von Hörsten, S., Schmitt, I., Nguyen, H. P., Holzmann, C., Schmidt, T., Walther, T., Bader, M., Pabst, R., Kobbe, P., Krotova, J., Stiller, D., Kask, A., Vaarmann, A., Rathke-Hartlieb, S., Schulz, J. B., Grasshoff, U., Bauer, I., Vieira-Saecker, A. M., Paul, M., Jones, L., Lindenberg, K. S., Landwehrmeyer, B., Bauer, A., Li, X. J., and Riess, O. (2003). Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 12, 617-624.
139. Vonsattel, J P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., and Richardson, E. P. Jr. (1985). Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
140. Walker, A. G., Miller, B. R., Fritsh, J. N., Barton, S. J., and Rebec, G. V. (2008). Altered information processing in the proforntal cortex of Huntington's Disease mouse models. J. Neurosci. 28, 8973-8982.
141. Walker, A. G., Ummel, J. R., and Rebec, G. V. (2011). Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's Disease is related to abnormal activity in prelimbic cortex. Neurobiol. Dis. 43, 379-87.
142. Woodman, B., Butler, R., Landles, C., Lupton, M. K., Tse, J., Hockly, E., Moffitt, H., Sathasivam, K., and Bates, G. P. (2007). The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res. Bull. 72, 83-97.
143. Yu, Z. X., Li, S. H., Evans, J., Pillarisetti, A., Li, H., and Li, X. J. (2003). Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J. Neurosci. 23, 2193-2202.
144. Zuccato, C., and Cattaneo, E. (2009). Brain-derived neurotrophic factor in neurodegenerative diseases. Nat. Rev. Neurol. 5, 311-322.